NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/08/2022
Back to search
Official data from USPTO
ONCOZENGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOZENGE
ST13
US500000090641383Class
5, 10, 35, 42, 45
Filing
90641383
Registration
6891963
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
11/08/2022
Trademark type
Word
Nice classes
5, 10, 35, 42, 45
Filing date
04/13/2021
Registration date
11/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2022
Last transaction
11/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
09
Owner location
Bromma, SE
Examiner
JOHN, CRISTEL M
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OncoZenge AB
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsparticularly in the fields of dermatologyinfectious diseases; disinfectant preparationspharmaceutical preparations with antimicrobialemollient and/or ceratolytic properties; pharmaceutical preparations for use in dermatology; medical preparations for the treatment or prevention of onychomycosisathletes foot and other dermatological foot conditionsvaginal fungal infections and other fungal infections; emollient creams for medical purposes; medicated surgical compresses pre-treated with preparations for treating fungal infections; pharmaceutical preparations for treatment of genital warts
Class 10
Medical devices for retarding the effect of medical substances and for delivering medicines to the body for the treatment or prevention of skin diseases and infections of the mucous membranes
Class 35
Advertising; business management consulting relating to pharmaceuticalmedicine and life sciences; business administration relating to pharmaceuticalmedicine and life sciences; office functions relating to pharmaceuticalmedicine and life sciences; advertising of pharmaceutical productscosmetic products and medical devices; commercial management assistance; demonstration of goods for promotional purposes relating to pharmaceuticalmedicine and life science products and services; distribution of samples relating to pharmaceuticalmedicine and life sciences for publicity purposes; import-export agency services relating to pharmaceuticalmedicine and life sciences; provision of commercial information relating to pharmaceuticalmedicine and life sciences; medical cost management; promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcare; Promotional sponsorship of pharmaceuticalmedicine and life sciences for advertising purposes
Class 42
Scientific and technological servicesresearch and design in the field of pharmaceuticalmedicine and life sciences; Scientific and technological servicesscientific research and design for others in the field of pharmaceuticals; Scientific and technological servicesconducting and evaluating clinical trials in the field of analgesic pain treatment; Chemical analysisanalysis of pharmaceutical products
Class 45
Legal services; licensing of intellectual property rights; Legal services relating to the exploitation of intellectual property rights
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/16/2021
GNRT
NON-FINAL ACTION E-MAILED
12/16/2021
CNRT
NON-FINAL ACTION WRITTEN
12/16/2021
DOCK
ASSIGNED TO EXAMINER
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2021
NWAP
NEW APPLICATION ENTERED
04/16/2021
Continuous trademark protection
Get notified about every new filing that threatens ONCOZENGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.